What biomarker testing is recommended for metastatic Pancreatic Cancer

Biomarker Testing for Metastatic Pancreatic Cancer

Based on current medical guidelines, here's what you should know about biomarker testing if you have metastatic pancreatic cancer:

What Testing Is Recommended

According to the NCCN Guidelines for Pancreatic Cancer (2025), molecular profiling (biomarker testing) is strongly recommended for patients with metastatic pancreatic cancer who are candidates for anti-cancer therapy. This testing helps identify which treatments might work best for your specific tumor.

Preferred Testing Method

Next-generation sequencing (NGS) is the gold standard. This is a comprehensive DNA test that can detect multiple types of genetic changes in your cancer cells at once. Testing on tumor tissue is preferred, but if tissue isn't available, a blood test (cell-free DNA) can be used as an alternative.

What Biomarkers Are Tested For

Your doctor will look for several types of genetic changes that have specific treatments available:

| Type of Change | Examples | What This Means | |---|---|---| | Gene Fusions | NTRK, RET, FGFR2, ALK, NRG1, ROS1 | Pieces of genes joined together; can be targeted with specific drugs | | Gene Mutations | KRAS, BRCA1/BRCA2, PALB2, BRAF | Changes in individual genes; different mutations respond to different treatments | | Gene Amplifications | HER2 | Extra copies of a gene; may respond to targeted therapies | | Microsatellite Instability (MSI) | — | Errors in DNA copying; may respond to immunotherapy | | Mismatch Repair Deficiency (dMMR) | — | Inability to fix DNA errors; may respond to immunotherapy | | Tumor Mutational Burden (TMB) | — | Total number of DNA changes; high burden may respond to immunotherapy |

Treatment Examples Based on Biomarkers

According to the NCCN Guidelines, here are some examples of how results guide treatment:

• BRCA1, BRCA2, or PALB2 mutations: PARP inhibitors like rucaparib (Rubraca) or platinum-based chemotherapy
• BRAF V600 mutations: Dabrafenib (Tafinlar) + trametinib (Mekinist)
• NTRK fusions: Entrectinib (Rozlytrek) or larotrectinib (Vitrakvi)
• RET fusions: Selpercatinib (Retevmo)
• MSI or dMMR: Immunotherapy drugs like pembrolizumab (Keytruda) or dostarlimab (Jemperli)
• KRAS mutations: Newer targeted therapies and combinations with chemotherapy or immunotherapy

Genetic Testing (Different from Biomarker Testing)

The NCCN Guidelines also recommend genetic testing (testing your normal cells, not just cancer cells) for inherited mutations. About 12% of pancreatic cancer patients have an inherited predisposition. This is important because:

• It may affect your treatment options
• Family members may need screening
• You may be eligible for specific clinical trials

Genes tested include: BRCA1, BRCA2, PALB2, ATM, CDKN2A, MLH1, MSH2, MSH6, PMS2, STK11, and TP53.

Important Practical Points

According to Dr. [removed] O'Reilly (a leading pancreatic cancer specialist), you should:

✓ Get "point of care" genetic testing at your first appointment—both hereditary testing and tumor testing ✓ Ask your doctor: "Have you done molecular profiling on my cancer? Can I see the report?" ✓ Keep a copy of your molecular profiling report—it often doesn't automatically transfer between hospitals ✓ Bring it to second opinions since this critical information sometimes gets left behind

Why This Matters

As the NCCN Guidelines emphasize: "Because of molecular biomarkers, a treatment that helps one person might not help you." This testing is how your doctor personalizes your treatment plan rather than using a one-size-fits-all approach.

---

Questions to Ask Your Oncology Team

1. Have you ordered molecular profiling (biomarker testing) on my tumor? If not, why not?
2. What type of testing will be done? (Should be next-generation sequencing)
3. Will you test tissue or blood, and why?
4. When will results be available, and how will you explain them to me?
5. Are there any actionable mutations found that change my treatment options?
6. Should I also have genetic testing for inherited mutations?
7. Can you provide me with a written copy of my molecular profiling report?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.